Persistent pain alters how the body responds under stress, and this guide explains how chronic pain may influence the readings during a lie detector test.
Chronic pain affects over 60 million American adults and fundamentally alters the physiological signals that polygraph instruments measure. This comprehensive guide explains how pain conditions disrupt baselines, what role medications play, and the accommodations examiners should make to ensure fair and accurate testing.
TL;DR — The Short Version
- Chronic pain disrupts physiological baselines — Pain elevates heart rate, blood pressure, and respiratory irregularities, making it harder for examiners to distinguish genuine deception-related reactions from pain-generated physiological noise.
- Medications complicate results — Opioids, muscle relaxants, beta-blockers, and anti-anxiety medications can dampen or distort the autonomic nervous system responses that polygraph instruments rely on, potentially producing flat tracings or inconclusive results.
- Testing is often still possible — With proper accommodations, strategic scheduling, and an experienced examiner, many chronic pain sufferers can successfully complete a valid polygraph examination.
- Always disclose your condition — Inform your examiner about your diagnosis, current medications, and pain levels before testing. Full disclosure is critical for accurate baseline calibration.
- Accommodations make a real difference — Ergonomic seating, shorter sessions, strategic breaks, adjusted sensor placement, and extended pre-test phases all improve the reliability of test outcomes.
- Some conditions may require postponement — Severe uncontrolled pain, heavy sedation from medications, or acute flares may make testing inadvisable until conditions stabilize.
Who This Guide Is For
- Individuals with chronic pain conditions who need to take a polygraph test
- Polygraph examiners who encounter examinees with chronic pain
- Attorneys and legal professionals ordering polygraph examinations for clients with medical conditions
- PCSOT examiners working with offender populations who have pain management issues
- Therapists and medical professionals advising patients about polygraph suitability
- Employers considering polygraph testing for employees or candidates with known pain conditions
Understanding Chronic Pain and Polygraph Science
What Is Chronic Pain?
Chronic pain is defined as persistent pain that lasts or recurs for more than three months, often continuing well beyond the expected period of healing from an injury or illness Verified Polygraph Results Explained
Confirms medical disorders, breathing irregularities, and muscle spasms can cause distorted polygraph charts requiring 'no opinion' determination.
Electrodermal Activity (EDA) Alterations
The electrodermal activity channel measures tiny changes in skin conductance driven by eccrine sweat gland activity, which is controlled exclusively by the sympathetic nervous system. Chronic pain can affect EDA in several ways.
First, chronic sympathetic activation can lead to elevated baseline skin conductance, meaning the examinee starts from a higher baseline. This can reduce the dynamic range available for meaningful responses. Second, some chronic pain conditions — particularly neuropathic conditions — can directly affect peripheral nerve function, potentially altering sweat gland responsiveness in specific body regions. Small fiber autonomic neuropathies often result in loss of sweating and changes in heart rate and blood pressure variation Verified Global Polygraph Network FAQ: Medications and Polygraph Results
Confirms no medication will cause someone to pass a polygraph when they would otherwise fail; CNS suppressants increase likelihood of inconclusive results.
Muscle relaxants such as cyclobenzaprine, methocarbamol, and tizanidine can have similar sedating effects. Baclofen, a GABA-B agonist used for spasticity and some pain conditions, is particularly notable for its CNS-depressant properties.
Antidepressants and Anticonvulsants Used for Pain
Tricyclic antidepressants (amitriptyline, nortriptyline) and serotonin-norepinephrine reuptake inhibitors (duloxetine, venlafaxine) are commonly prescribed for neuropathic pain and fibromyalgia. These medications have anticholinergic effects that can reduce skin conductance and alter cardiovascular parameters. Antidepressant medications, including SSRIs and tricyclics, may further reduce physiological reactivity, leading to inconclusive charts Verified Global Polygraph Network FAQ: Medications and Polygraph Results
Confirms no medication will cause someone to pass a polygraph when they would otherwise fail; CNS suppressants increase likelihood of inconclusive results.
Advanced computerized scoring systems, such as PolyScore and CPS, may offer advantages when evaluating charts from chronic pain patients. These algorithms apply consistent mathematical analysis that can account for baseline variability more objectively than manual scoring alone.
Research on the detection of genuine versus faked pain expressions provides relevant context. Craig and Hill (2003) found that human observers showed poor accuracy — approximately 49% — at discriminating genuine from faked pain expressions Verified Detecting deception in pain expressions: the structure of genuine and deceptive facial displays
Foundational research on distinguishing genuine from deceptive pain expressions, published in the journal Pain. Hill and Craig (2002) published complementary findings in the journal Pain on the structure of genuine and deceptive facial pain displays Verified Results of Polygraph Examinations: Direct or Circumstantial Evidence?
Confirms polygraph results are classified as circumstantial evidence requiring logical inference; relevant to understanding how medical conditions add complexity to interpretation. These studies underscore the complexity of assessing pain-related behaviors and the importance of objective measurement tools.
Polygraph results in complex medical cases should be understood as circumstantial evidence requiring logical inference, as Widacki (2014) explained in his analysis of polygraph evidence classification Verified Debunking Myths: Why Methods to Beat a Lie Detector Test Don't Work
Confirms countermeasure techniques are detectable and counterproductive; relevant context for chronic pain patients who may be advised to try relaxation techniques. This perspective is especially relevant when medical conditions introduce additional variables into the physiological data.
When to Defer Testing
There are situations when the most professional and responsible decision is to defer testing until conditions improve. Indicators that testing should be postponed include:
Pain levels reported at 7 or above on a 0-10 scale, suggesting the examinee cannot maintain adequate focus or physiological stability.
Recent changes in medication type or dosage (within the past 2-4 weeks), as the body may not yet have reached a stable physiological state.
Active disease flares in conditions such as rheumatoid arthritis, fibromyalgia, or CRPS.
Visible distress, inability to sit still, or frequent position changes that would compromise chart quality.
Heavy sedation from medications that would impair cognitive engagement with the test.
The decision to defer is not a failure — it is a quality assurance measure that protects both the integrity of the examination and the well-being of the examinee. Understanding the full criteria for polygraph examination disqualification helps examiners make informed decisions. A polygraph retest under better conditions will yield far more reliable results than pushing through when the examinee's medical state compromises data quality.
Legal and Ethical Considerations
ADA Compliance and Medical Disclosure
When polygraph testing is required for employment purposes, the Americans with Disabilities Act (ADA) creates important considerations for examinees with chronic pain. Examiners must balance the need to assess medical suitability for testing against ADA restrictions on medical inquiries, particularly in pre-employment contexts.
Physicians can play an important advisory role. A physician's responsibility when in administrative or supervisory positions may include advising security and other officials regarding the fitness of candidates for polygraph examination and the validity of such results [5]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System
Confirms polygraph results are vulnerable to inaccuracies in subjects with autonomic disorders and may be confounded by multiple medications; documents that 5 of 10 most prescribed medications affect ANS. However, when a physician-patient relationship exists, care must be given to ensure patient confidentiality is protected [5]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System
Confirms polygraph results are vulnerable to inaccuracies in subjects with autonomic disorders and may be confounded by multiple medications; documents that 5 of 10 most prescribed medications affect ANS. Disclosure of medical conditions cannot be made without the patient's consent, save in very specific legal situations [5]Verified Beyond the Polygraph: Deception Detection and the Autonomic Nervous System
Confirms polygraph results are vulnerable to inaccuracies in subjects with autonomic disorders and may be confounded by multiple medications; documents that 5 of 10 most prescribed medications affect ANS.
Records of medical disclosure obtained during the polygraph pre-test phase are confidential and must be stored in compliance with applicable data protection laws [18]Verified Medical and Psychological Conditions Affecting Polygraph Examinations
Confirms APA, ASTM E2031, and ENFSI guidelines require examiners to recognize health issues that may compromise validity; documents informed consent requirements. The examiner should document all medical disclosures and accommodations provided, as this documentation may be important if the examination results are later reviewed or challenged.
PCSOT and Criminal Justice Contexts
In post-conviction sex offender testing (PCSOT) settings, chronic pain is a particularly common concern. Many individuals in offender supervision programs are older adults with multiple chronic conditions. The therapeutic value of polygraph testing in sex offender rehabilitation is well-established, and chronic pain should not automatically exclude individuals from participation.
PCSOT examiners should work closely with treatment providers to build therapeutic alliances that account for medical needs. Stanley Abrams, a pioneer in clinical polygraph applications, emphasized the importance of adapting polygraph procedures to accommodate individual clinical needs.
For juvenile offender populations, the intersection of developmental factors with chronic pain conditions requires even more specialized attention. In all criminal justice contexts, the goal is to ensure that medical conditions do not produce false results — either false positives that unfairly penalize truthful examinees or false negatives that allow deception to go undetected.
How to Prepare for a Polygraph If You Have Chronic Pain
Pre-Test Preparation Steps
If you have chronic pain and need to take a polygraph test, proper preparation can significantly improve your experience and the accuracy of results. Follow these essential steps:
Disclose everything in advance: Contact your examiner before the test date to discuss your pain condition, all medications, and any accommodations you may need. Full transparency allows the examiner to plan appropriately and helps ensure accurate baseline calibration.
Maintain your normal medication schedule: Do not skip or alter your pain medications for the test unless specifically advised by your physician. Sudden changes in medication can cause withdrawal effects or increased pain that further disrupts physiological baselines.
Schedule strategically: If possible, schedule your examination during the time of day when your pain is typically most manageable. Avoid testing after poor sleep, during a flare, or following strenuous activity that may worsen your symptoms.
Prioritize rest the night before: Good sleep is important for cognitive engagement during the test. Research on sleep deprivation and polygraph testing has shown that 24 hours of sleep deprivation did not significantly reduce detection accuracy [15]Verified On the Influence of Sleep Deprivation on the Results of Polygraph Testing
Confirms 24-hour sleep deprivation did not significantly reduce polygraph detection accuracy; provides context for evaluating fatigue-related factors in chronic pain patients, but chronic pain patients who are well-rested will produce cleaner physiological data.
Bring documentation: Have a current medication list with dosages, timing, and your prescribing physician's contact information. A brief note from your doctor describing your condition can be helpful.
Practice relaxation: Techniques such as slow, controlled breathing can help manage both pain and anxiety during the examination. While countermeasure techniques are detectable and counterproductive, genuine relaxation approaches that help manage pain are appropriate and beneficial.
Disclose Your Condition Early
Contact your examiner before the test date to discuss your chronic pain diagnosis, all current medications with dosages, and any specific accommodations you may need. This allows proper preparation and baseline adjustment.
Maintain Your Medication Schedule
Take your medications as normally prescribed. Do not skip or alter doses for the test — sudden medication changes cause physiological instability that makes accurate testing more difficult.
Schedule at Your Best Time
Work with your examiner to schedule the test during the time of day when your pain is typically most manageable. Avoid testing during known flare periods or after activities that worsen your symptoms.
Prepare Your Body and Mind
Get adequate sleep the night before, eat a light meal, stay hydrated, and avoid caffeine excess. Bring lumbar support or comfort items if permitted.
Communicate During the Test
Tell your examiner if your pain escalates during the examination. Request breaks if needed. Your honesty about your comfort level helps produce more reliable data.
Bring Medical Documentation
Have a current medication list, physician contact information, and any relevant medical notes. This helps the examiner make informed decisions about testing suitability and accommodations.
Pros
- Testing is possible for most chronic pain patients with proper accommodations and experienced examiners
- Modern polygraph instruments record multiple physiological channels, allowing examiners to cross-reference data for accuracy
- APA standards require examiners to consider medical conditions, ensuring professional accountability
- Computerized scoring algorithms can help account for baseline variability more objectively
- Full medical disclosure helps examiners calibrate baselines more accurately for fair results
- Retesting options are available if initial results are inconclusive due to pain-related factors
Cons
- Chronic pain can elevate physiological baselines, reducing the dynamic range available for detecting meaningful responses
- Pain medications — especially opioids, benzodiazepines, and beta-blockers — can dampen autonomic responsiveness
- Cognitive competition from pain processing may reduce the examinee's ability to fully engage with test questions
- Certain conditions like CRPS may require modified sensor placement that limits available data channels
- Acute flares or severe pain may necessitate postponement, creating scheduling challenges
- Central sensitization can amplify all physiological responses, making it harder to identify deception-specific signals
Frequently Asked Questions
Can I take a polygraph test if I have chronic pain?
Yes, in most cases. With proper accommodations, medication management, and an experienced examiner, many chronic pain sufferers can complete a valid polygraph examination. The key is full disclosure of your condition and medications before testing. Only severe, uncontrolled pain or heavy sedation from medications may make testing inadvisable until conditions stabilize.
Should I stop taking my pain medications before a polygraph test?
No — you should not stop or alter your pain medications without consulting your physician. Sudden medication changes can cause withdrawal effects, rebound pain, or physiological instability that makes testing even more difficult. Maintain your normal medication schedule and disclose all medications to your examiner before the test.
Will my pain medications cause me to fail the polygraph?
Pain medications do not cause people to 'fail' a polygraph test. However, certain medications — particularly opioids, benzodiazepines, and beta-blockers — can reduce the strength of physiological reactions on polygraph charts, potentially resulting in inconclusive rather than definitive results. There is no medication that will cause someone to pass a polygraph when they would otherwise fail.
How does fibromyalgia specifically affect polygraph testing?
Fibromyalgia presents unique challenges because it involves central sensitization (amplified nervous system signaling), cognitive difficulties ('fibro fog'), and often requires multiple medications. These factors can affect all three primary measurement channels. However, testing is not automatically contraindicated — it requires careful assessment of symptom severity on the day of testing and potentially more accommodations than other pain conditions.
What accommodations can I request for chronic pain during a polygraph?
You can request ergonomic seating with lumbar support, strategic breaks between chart collections, scheduling at your best time of day, modified sensor placement if you have conditions affecting specific body areas, and a shorter overall testing session when possible. Experienced examiners are familiar with these accommodations and should be willing to implement them.
Can chronic pain cause a false positive on a polygraph test?
Chronic pain can produce physiological responses — such as elevated heart rate, blood pressure spikes, or breathing irregularities — that may be mistaken for deception-related signals if the examiner is not aware of the pain condition. This is why full disclosure is essential. An experienced examiner who knows about your condition can account for pain-related artifacts during scoring.
What if my polygraph results are inconclusive because of my pain condition?
Inconclusive results mean the examiner could not determine truth or deception from the data collected. This is not a failure — it simply means a definitive determination was not possible. In most cases, a retest can be scheduled under more optimal conditions, such as during a period of better pain control or at a different time of day.
Does the APA have specific guidelines for testing people with chronic pain?
The APA Standards of Practice require examiners to make reasonable efforts to determine that the examinee is a suitable candidate for polygraph testing and to consider mental, physical, or medical conditions when conducting and evaluating examinations. While there are no chronic pain-specific protocols, the general medical screening and accommodation requirements apply directly to pain conditions.
Should I inform my attorney about my chronic pain before a polygraph test?
Absolutely. If you are taking a polygraph in a legal context, your attorney should know about your chronic pain condition and medications. This information may be relevant if results need to be interpreted or challenged. Your attorney can also communicate your medical needs to the examiner in advance to ensure appropriate accommodations are arranged.
Can medical cannabis use affect my polygraph results?
Yes. THC can increase heart rate and alter autonomic nervous system function, while CBD may cause mild sedation. If you use medical cannabis for pain management, disclose this to your examiner. The examiner should note its potential effects and account for any autonomic changes during scoring. Using cannabis with medical authorization does not invalidate testing but should be documented.
Sources & References
Confirms IASP/WHO classification of chronic pain as a health condition in its own right, defining chronic pain as pain persisting or recurring for more than 3 months
Confirms 24.3% of U.S. adults had chronic pain in 2023, and 8.5% had high-impact chronic pain (CDC NCHS Data Brief No. 518)
Confirms 20.9% prevalence (51.6 million persons) in 2021, documents links between chronic pain and depression, suicide risk, and substance misuse
Confirms chronic pain was higher among women (25.4%) than men (23.2%) in 2023, with prevalence increasing with decreasing urbanicity
Confirms polygraph results are vulnerable to inaccuracies in subjects with autonomic disorders and may be confounded by multiple medications; documents that 5 of 10 most prescribed medications affect ANS
Confirms interrogative examiner approaches compromise polygraph validity; supports the importance of professional examiner conduct with chronic pain patients
Foundational research demonstrating that emotional arousal produces unified sympathoadrenal activation — the same physiological changes polygraphs measure
Confirms pain activates the sympathetic nervous system increasing peripheral resistance, heart rate, and stroke volume; documents the pathophysiological differences between acute and chronic pain cardiovascular effects
Confirms 39% of chronic pain patients had clinical hypertension vs. 21% of non-pain patients (P < 0.001); chronic pain intensity was an independent predictor of hypertension
Confirms 2025 study of 200,000+ adults showing chronic widespread pain is linked to higher risk of developing high blood pressure; depression and inflammation accounted for 11.7% of the association
Confirms central sensitization is an amplification of neural signaling within the CNS that elicits pain hypersensitivity; notes dysfunction of the autonomic system as a predisposing factor
Confirms the autonomic nervous system, endocrine and immune systems all affect central sensitization experience; documents the role of neuroinflammation
Confirms central sensitization likely caused by neurotransmitter dysregulation, nervous system inflammation, and dysfunction of the autonomic fight-or-flight response
Confirms 24-hour sleep deprivation did not significantly reduce polygraph detection accuracy; provides context for evaluating fatigue-related factors in chronic pain patients
Confirms chronic opioid receptor stimulation decreases sympathetic nervous system activity — directly relevant to polygraph responsiveness in opioid-treated patients
Confirms APA, ASTM E2031, and ENFSI guidelines require examiners to recognize health issues that may compromise validity; documents informed consent requirements
Confirms up to 10% of the general population experience neuropathic pain; provides classification framework for chronic neuropathic pain conditions
Confirms examiners should make reasonable efforts to determine examinee suitability and make basic inquiries into medical and psychological condition
Confirms PVT successfully resolved all 51 cases of conflicted polygraph results; relevant tool for resolving ambiguous results in chronic pain patients
Confirms human observers showed approximately 49% accuracy at discriminating genuine from faked pain expressions; underscores complexity of pain assessment
Foundational research on distinguishing genuine from deceptive pain expressions, published in the journal Pain
Confirms polygraph results are classified as circumstantial evidence requiring logical inference; relevant to understanding how medical conditions add complexity to interpretation
Confirms countermeasure techniques are detectable and counterproductive; relevant context for chronic pain patients who may be advised to try relaxation techniques
If chronic pain could influence your results, discuss accommodations with a professional and book your lie detector test near you confidently.